COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 617
[93] Greene C, Hanley N, Campbell M. Blood-brain barrier
associated tight junction disruption is a hallmark feature of major
psychiatric disorders. Transl Psychiatry. 2020;10(1):373.
[94] Fung A, Vizcaychipi MP, Lloyd D, Wan Y, Ma D. Central
nervous system inflammation in disease related conditions:
mechanistic prospects. Brain Res. 2012;1446:144-155.
[95] Erickson MA, Hansen K, Banks WA. Inflammation-induced
dysfunction of the low-density lipoprotein receptor-related
protein-1 at the blood-brain barrier: protection by the antioxidant
N-acetylcysteine. Brain Behav Immun. 2012;26(7):1085-1094.
[96] Zlokovic BV. The blood-brain barrier in health and chronic
neurodegenerative disorders. Neuron. 2008;57(2):178-201.
[97] Nation DA, Sweeney MD, Montagne A, et al. Blood-brain
barrier breakdown is an early biomarker of human cognitive
dysfunction. Nat Med. 2019;25(2):270-276.
[98] Verheggen ICM, de Jong JJA, van Boxtel MPJ, et al. Increase
in blood-brain barrier leakage in healthy, older adults.
Geroscience. 2020;42(4):1183-1193.
[99] Barnes SR, Ng TSC, Montagne A, Law M, Zlokovic BV, Jacobs
RE. Optimal acquisition and modeling parameters for accurate
assessment of low Ktrans blood-brain barrier permeability using
dynamic contrast-enhanced MRI. Magn Reson Med.
2016;75(5):1967-1977.
[100] Heye AK, Culling RD, Valdés Hernández MDC, Thrippleton
MJ, Wardlaw JM. Assessment of blood-brain barrier disruption
using dynamic contrast-enhanced MRI. A systematic review.
Neuroimage Clin. 2014;6:262-274.
[101] Narantuya D, Nagai A, Sheikh AM, et al. Human microglia
transplanted in rat focal ischemia brain induce neuroprotection
and behavioral improvement. PLoS One. 2010;5(7):e11746.
617
